Researcher Profile

F.C. Bidard

0000-0001-5932-8949

Publications

255

Citations

Co-Authors

Active Years

Publications

Open Access Journal Article ESMO Open Mar 01, 2026

Imlunestrant plus abemaciclib versus fulvestrant plus abemaciclib in ER-positive, HER2-negative advanced breast cancer: an indirect treatment comparison of three phase III trials

K. Jhaveri · F.C. Bidard · K. Kalinsky · P. Neven +8 more

10.1016/j.esmoop.2026.106091

Open Access Journal Article Annals of Oncology Nov 01, 2025

Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER-positive/HER2-negative breast cancer

A. Mamann · Y. Pradat · F.C. Bidard · S. Delaloge +21 more

10.1016/j.annonc.2025.06.015 5 citations

Open Access Journal Article Annals of Oncology May 01, 2016

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)

H. Bonnefoi · T. Grellety · O. Tredan · M. Saghatchian +19 more

10.1093/annonc/mdw067 241 citations

Journal Article European Journal of Surgical Oncology (EJSO) Dec 01, 2012

Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma

C. Ngo · D. Mouttet · Y. De Rycke · F. Reyal +7 more

10.1016/j.ejso.2012.08.007 9 citations

Publication Timeline

2026

2025

2016

2012

Frequent Co-Authors

2×

1×

1×

1×

1×

1×

1×

1×

1×

1×